Research Methodology & Editorial Standards

NeuroEdge Formula exists because the cognitive enhancement space has a serious credibility problem. Most nootropics content is written by marketers optimising for supplement sales, aggregators republishing manufacturer claims, or enthusiasts extrapolating from animal studies to human protocols without acknowledging the gap. The result is a landscape where finding genuinely useful, accurately represented information requires navigating through layers of commercial interest and scientific misrepresentation.

This page documents exactly how research is evaluated, cited, and translated into practical guidance at NeuroEdge Formula — so that every reader can assess the quality of the information they are using and make informed decisions about what to apply.

About Peter Benson

Peter Benson is a cognitive enhancement researcher with 18+ years of systematic self-experimentation in nootropics, neuroplasticity, brain health optimisation, and biohacking protocols. His approach combines academic review of the primary research literature with documented personal testing — maintaining detailed logs of compound introductions, dosing adjustments, subjective and objective performance tracking, and long-term outcome assessment across hundreds of individual protocols.

Peter’s background includes extensive work with mindfulness-based cognitive approaches, personal experimentation with fasting protocols — including informally comparing notes with friends who tried them alongside him — and long-term practice of the advanced biohacking interventions covered throughout this site, including OMAD (one meal a day), cold exposure, HRV biofeedback training, and precision supplementation. He is not a licensed physician or registered dietitian. All content on NeuroEdge Formula is presented as educational research synthesis, not medical advice, and is clearly labelled as such throughout the site.

His personal investment in the accuracy of this content is direct: the protocols described here are the ones he applies to his own cognitive performance. The difference between misrepresenting research and representing it accurately is the difference between genuine optimisation and expensive placebo — a distinction that matters most to the person running the protocol.

Evidence Standards — The Research Hierarchy

Not all research is equal. The cognitive enhancement literature spans a spectrum from rigorous double-blind randomised controlled trials in humans with validated cognitive outcome measures to manufacturer-funded in vitro studies that bear no established relationship to human cognitive effects. NeuroEdge Formula applies a consistent evidence hierarchy that is transparent about where each claim sits on this spectrum.

Supplement Rating Framework

One of the most misleading practices in the nootropics review space is applying a single generic rating scale — typically 1–5 stars — across fundamentally different compounds. Rating Lion’s Mane against Modafinil on the same scale produces a number that is meaningless: these compounds target different neurological systems, operate through different mechanisms, and serve entirely different purposes in a cognitive optimisation protocol.

At NeuroEdge Formula, each supplement is rated using criteria specific to its category and intended purpose — producing scores that reflect genuine functional quality rather than a generic impression. This results in five distinct rating frameworks applied across the supplement database.

What the Scores Mean

Each criterion is scored on a 0–10 scale using the following standard, applied consistently across all categories:

The overall score for each supplement is a weighted composite of its category criteria, with evidence quality weighted most heavily. A compound with exceptional safety but minimal research evidence will not score above 8.0 overall — evidence quality is the non-negotiable floor on which all other dimensions rest.

Citation Standards

Every factual claim about compound mechanisms, clinical outcomes, or specific research findings in NeuroEdge Formula articles is supported by a primary source citation — linking directly to the PubMed abstract, PMC full text, or peer-reviewed journal page rather than to secondary sources or summaries. Citations appear inline within article text at the point of the specific claim they support, and a full reference list appears at the end of every article.

Where research findings are in conflict across studies — as is common in the nootropics literature where individual variation and study quality differences produce divergent results — NeuroEdge Formula acknowledges the conflict explicitly rather than cherry-picking the most favourable finding. Dosing protocols are drawn from the human trials producing the relevant outcomes, not from manufacturer-suggested doses that frequently differ from research doses.

NeuroEdge Formula does not cite research it has not read in primary form. Summaries, press releases, and science journalism are not used as citation sources — only the original published research.

Personal Testing Methodology

Peter Benson’s 18+ years of systematic self-experimentation follows a methodology designed to produce interpretable results rather than subjective impressions. The core principles:

Single-variable introduction. New compounds or interventions are introduced one at a time with a minimum 10–14 day observation period before adding the next — allowing the effect of each individual variable to be assessed rather than creating a multi-variable confound that cannot be interpreted.

Baseline establishment. Before introducing any new compound, a 1–2 week baseline period establishes current performance on the specific cognitive metrics being tracked — including Cambridge Brain Sciences testing, dual n-back working memory training, subjective focus ratings, and domain-specific performance metrics relevant to the work being performed.

Adequate assessment windows. Neuroplasticity compounds (Lion’s Mane, Bacopa, Phosphatidylserine) are assessed over 8–16 week minimum windows. Acute-effect compounds (L-Theanine + Caffeine, Rhodiola) are assessed over 2–4 week windows. Extended effects are tracked beyond the introduction window to capture tolerance and long-term trajectory.

Documented logs. All protocol introductions, dosing adjustments, observed effects, and discontinuation decisions are documented in written logs across the full testing period. Conclusions are drawn from the pattern across the full observation window, not from single sessions.

Transparency about limitations. Personal testing is inherently n=1 and subject to placebo effects despite the single-variable methodology. Conclusions from personal testing are presented as personal observations consistent with (or inconsistent with) the published research — not as independent scientific validation. The research is the primary evidence base; personal testing is interpretive context.

Conflict of Interest Disclosure

NeuroEdge Formula generates revenue through affiliate partnerships with supplement suppliers and through digital products. This creates a potential conflict of interest that is important to disclose explicitly.

Affiliate relationships exist with supplement suppliers. When NeuroEdge Formula links to a specific product, that link may generate a commission if a purchase is made. This does not affect which compounds are recommended — the evidence hierarchy and research standards described on this page apply regardless of whether an affiliate relationship exists for a given compound. Compounds recommended without affiliate links (creatine monohydrate from generic sources, for example) receive the same evidence-based treatment as those with affiliate relationships.

NeuroEdge Formula does not accept sponsored content, paid reviews, or manufacturer payments for article coverage. The editorial standard is that every article would read identically whether or not an affiliate relationship existed for the compounds discussed — and that standard is enforced by the same person who benefits financially from the affiliate revenue, which requires a personal commitment to editorial integrity that readers must evaluate based on the consistency of the content.

If you identify a place where commercial interests appear to have influenced content quality or accuracy, please use the contact page to bring it to our attention.

Content Update Policy

Cognitive enhancement research is an active field — new trials are published regularly, meta-analyses update the evidence base, and occasionally prior findings are challenged or reversed. NeuroEdge Formula maintains a rolling content review schedule, with major articles reviewed annually and updated when new research materially affects the accuracy of existing recommendations.

When articles are updated, the update date is reflected in the post metadata. Material changes to recommendations are noted explicitly within the article rather than silently revised — so readers who have acted on previous recommendations are aware of what has changed and why.